Others have used ELISAs to demonstrate that activation of the alternative complement pathway and decreased levels of CFP correlate with severity and mortality of COVID‐19 (Boussier et al., 2022; Siggins et al., 2023). The gene discussed is CFP; the disease is COVID-19.